Palladium-Catalyzed Oxidative CH Bond Acylation of Acetanilides with Benzylic Alcohols
作者:Yu Yuan、Duanteng Chen、Xiaowei Wang
DOI:10.1002/adsc.201100417
日期:2011.12
An efficient and clean method to construct CC bonds has been developed via the acylation reaction of acetanilides with benzylic alcohols using tert-butyl hydroperoxide (TBHP) as oxidant catalyzed by palladium acetate in the presence of triflic acid (TfOH). The acylation reactions exhibit excellent reactivities, and up to 95% yield of the corresponding aryl ketone could be obtained under the optimal
Toluene derivatives as simple coupling precursors for cascade palladium-catalyzed oxidative C–H bond acylation of acetanilides
作者:Yinuo Wu、Pui Ying Choy、Fei Mao、Fuk Yee Kwong
DOI:10.1039/c2cc37352a
日期:——
A palladium-catalyzed cascade cross-coupling of acetanilide and toluene for the synthesis of ortho-acylacetanilide is described. Toluene derivatives can act as effective acyl precursors (upon sp(3)-C-H bond oxidation by a Pd/TBHP system) in the oxidative coupling between two C-H bonds. This dehydrogenative Pd-catalyzed ortho-acylation proceeds under mild reaction conditions.
Palladium-Catalyzed ortho-Acylation of Acetanilides with Aldehydes through Direct CH Bond Activation
作者:Chengliang Li、Lei Wang、Pinhua Li、Wei Zhou
DOI:10.1002/chem.201101192
日期:2011.9.5
Easy access to o‐acyl acetanilides: A new Pd‐catalyzed ortho‐acylation of acetanilides with both aromatic and aliphatic aldehydes has been developed based on a CH activation process. In the presence of tert‐butyl hydroperoxide (TBHP) as the ideal oxidant, this reaction provides an efficient access to ortho‐acyl acetanilides in good yields (see scheme).
BROMODOMAIN-INHIBITING COMPOUNDS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING A CANCER
申请人:KAINOS MEDICINE, INC.
公开号:US20170174702A1
公开(公告)日:2017-06-22
Provided is a novel compound having bromodomain and extra terminal domain (BET) protein inhibiting activities, and a pharmaceutical composition comprising the same which can be useful for prevention or treatment of precancerous transformation or cancer.